Posttraumatic stress disorder after treatment for breast cancer: Prevalence of diagnosis and use of the PTSD checklist - Civilian version (PCL-C) as a screening instrument
Posttraumatic stress disorder after treatment for breast cancer: Prevalence of diagnosis and use of the PTSD checklist - Civilian version (PCL-C) as a screening instrument
复制标题
DOI：
10.1037/0022-006x.66.3.586
复制
发表时间：
1998-06-01
影响因子：
5.9
通讯作者：
Miller, TW
中科院分区：
文献类型：
--
作者：
Andrykowski, MA;Cordova, MJ;Miller, TW
诊断为 O-IIIA 期的女性 (n = 82) 存在创伤后应激障碍 (PTSD)。乳腺癌在癌症治疗后 6 至 72 个月进行评估。PTSD 检查表-民用版 (PCL-C) 和 DSM-IV 结构化临床访谈的 PTSD 模块、非患者版、PTSD 模块 (SCID-NP-PTSD) 通过电话访谈进行。 SCID-NP-PTSD 结果表明当前和终生 PTSD 的患病率分别为 6% 和 4%。使用 PCL-C 上推荐的截止分数 50 来确定当前癌症相关 PTSD 的诊断，结果灵敏度为 0.60，特异性为 0.99，有 2 个假阴性诊断。总之，乳腺癌的诊断和治疗可能会引发 PTSD，而 PCL-C 可以成为该疾病的一种经济有效的筛查工具。
The presence of a posttraumatic stress disorder (PTSD) diagnosis in women (n = 82) diagnosed with Stage O-IIIA. breast cancer was assessed 6 to 72 months after cancer therapy The PTSD Checklist-Civilian Version (PCL-C) and the PTSD module for the Structured Clinical Interview for DSM-IV, Nonpatient Version, PTSD module (SCID-NP-PTSD) were administered in a telephone interview. SCID-NP-PTSD results indicated prevalence rates of 6% and 4% for current and lifetime PTSD, respectively. Use of the recommended cutoff score of 50 on the PCL-C to determine diagnosis of current cancer-related PTSD resulted in a sensitivity of .60 and a specificity of .99 with 2 false-negative diagnoses. In conclusion, PTSD can be precipitated by diagnosis and treatment of breast cancer, and the PCL-C can be a cost-effective screening tool for this disorder.